Raplon
The following drug information is obtained from various newswires, published
medical journal articles, and medical conference presentations.
General Information
Raplon (rapacuronium bromide) has been approved as an adjunct to
general anesthesia to facilitate tracheal intubation, and to
provide skeletal muscle relaxation during surgical procedures.
Raplon was proven in studies to be an effective alternative to
succinylcholine with a rapid onset and a short duration of action
with the recommended dose.
Raplon is the first and only nondepolarizing neuromuscular
blocking agent (NMBA) that combines both rapid onset with short
duration for tracheal intubations and many short procedures
including appendectomy, tonsillectomy, cystectomy, tubal ligation,
and Cesarean section.
